Pharmaceutical - Novo Nordisk, Rare diseases

Filter

Current filters:

Novo NordiskRare diseases

Popular Filters

FDA approves Novo Nordisk’s Tretten to treat rare genetic clotting disorder

FDA approves Novo Nordisk’s Tretten to treat rare genetic clotting disorder

24-12-2013

The US Food and Drug Administration yesterday (December 23) approved Tretten, coagulation factor XIII…

HematologyNorth AmericaNovo NordiskNovoThirteenPharmaceuticalRare diseasesRegulationTretten

Novo Nordisk’s NovoEight passes first stage of Japanese approval

Novo Nordisk’s NovoEight passes first stage of Japanese approval

18-11-2013

Danish insulin giant Novo Nordisk’s recombinant factor VIII product NovoEight (turoctocog alfa) has…

Asia-PacificHematologyNovo NordiskNovoEightPharmaceuticalRare diseasesRegulation

Positive CHMP opinion for Novo Nordisk's NovoEight

Positive CHMP opinion for Novo Nordisk's NovoEight

20-09-2013

Danish insulin giant Novo Nordisk (NOV: N) revealed this morning that the European Medicines Agency’s…

EuropeNovo NordiskNovoEightPharmaceuticalRare diseasesRegulationturoctocog alfa

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus

20-12-2012

Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

Novo Nordisk files hemophilia drug turoctocog in USA and EU

17-10-2012

Denmark's Novo Nordisk (NOV: N), the world's largest insulin maker, has submitted regulatory application…

EuropeNorth AmericaNovo NordiskPharmaceuticalRare diseasesRegulationturoctocog alfa

Novo Nordisk drops vatreptacog development

30-09-2012

Danish insulin giant Novo Nordisk (NOV: N) says that it has decided to discontinue the development of…

Novo NordiskPharmaceuticalRare diseasesResearchvatreptacog

FDA expands Levemir use to young children; negative on tafamidis

23-05-2012

Denmark-based global insulin giant Novo Nordisk (NOV: N) says that the US Food and Drug Administration…

DiabetesLevemirNorth AmericaNovo NordiskPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

Back to top